Pamela Ting
@pamelating
ID: 1051289310387994624
14-10-2018 01:51:18
12 Tweet
109 Followers
48 Following
Today in Science Magazine, together with my former colleagues at NIBR, we report the discovery and characterization of first molecular glue degraders of the WIZ transcription factor (TF) for fetal hemoglobin derepression and therapeutic consideration in Sickle Cell Disease. 1/10
A major medical milestone late last year was the first #CRISPR genome editing approval (Casgevy) vs sickle cell disease. But it's very complicated and expensive. How about an epigenetic modifier pill with the same target, as seen here Science Magazine? science.org/doi/10.1126/sc…
Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies — My piece for Genetic Engineering & Biotechnology News on exciting new work from Pamela Ting Jay Bradner, M.D. and colleagues #sicklecell genengnews.com/news/gee-wiz-n… via Genetic Engineering & Biotechnology News
Excited to see this published in Science Magazine—our team’s paper on the discovery of molecular glue degraders to induce fetal hemoglobin—a potential avenue toward creating an accessible oral therapy for #sicklecelldisease. Congrats to Pamela Ting, Jay Bradner, M.D. and all involved
It’s incredible that we can treat sickle cell disease with CRISPR, but it’d be extremely useful to have a pill that does the same thing. Work from Pamela Ting Jay Bradner, M.D. in Science Magazine show it may be possible with a molecular glue small molecule!